hnRNPA2/B1 Ameliorates LPS-Induced Endothelial Injury through NF-κB Pathway and VE-Cadherin/β-Catenin Signaling Modulation In Vitro

Figure 1

hnRNPA2/B1 expression in LPS-stimulated HUVECs. HUVECs were treated with 1 μg/mL LPS for 0 h, 6 h, 12 h, and 24 h. (a) hnRNPA2/B1 mRNA expression levels were quantified by qRT-PCR, and β-actin was used as a normalization control. (b, c) hnRNPA2/B1 protein levels were measured by Western blotting, and GAPDH was used as an internal control. , , .

(a)

(b)

(c)